Microglial Extracellular Vesicles As Modulators of Brain Microenvironment in Glioma
Overview
Chemistry
Molecular Biology
Affiliations
Microglial cells represent the resident immune elements of the central nervous system, where they exert constant monitoring and contribute to preserving neuronal activity and function. In the context of glioblastoma (GBM), a common type of tumor originating in the brain, microglial cells deeply modify their phenotype, lose their homeostatic functions, invade the tumoral mass and support the growth and further invasion of the tumoral cells into the surrounding brain parenchyma. These modifications are, at least in part, induced by bidirectional communication among microglial and tumoral cells through the release of soluble molecules and extracellular vesicles (EVs). EVs produced by GBM and microglial cells transfer different kinds of biological information to receiving cells, deeply modifying their phenotype and activity and could represent important diagnostic markers and therapeutic targets. Recent evidence demonstrates that in GBM, microglial-derived EVs contribute to the immune suppression of the tumor microenvironment (TME), thus favoring GBM immune escape. In this review, we report the current knowledge on EV formation, biogenesis, cargo and functions, with a focus on the effects of microglia-derived EVs in GBM. What clearly emerges from this analysis is that we are at the beginning of a full understanding of the complete picture of the biological effects of microglial-derived EVs and that further investigations using multidisciplinary approaches are necessary to validate their use in GBM diagnosis and therapy.
Kanuri S, Sirrkay P Brain Circ. 2024; 10(3):193-204.
PMID: 39526104 PMC: 11542763. DOI: 10.4103/bc.bc_113_23.
T cell interactions with microglia in immune-inflammatory processes of ischemic stroke.
Zheng Y, Ren Z, Liu Y, Yan J, Chen C, He Y Neural Regen Res. 2024; 20(5):1277-1292.
PMID: 39075894 PMC: 11624874. DOI: 10.4103/NRR.NRR-D-23-01385.
Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry.
Liguori G Cells. 2024; 13(4.
PMID: 38391949 PMC: 10886570. DOI: 10.3390/cells13040336.
Jayanti S, Vitek L, Verde C, Llido J, Sukowati C, Tiribelli C Biomolecules. 2024; 14(1).
PMID: 38254662 PMC: 10813662. DOI: 10.3390/biom14010063.
Marangon D, Lecca D Front Cell Dev Biol. 2023; 11:1275755.
PMID: 38020906 PMC: 10646304. DOI: 10.3389/fcell.2023.1275755.